Literature DB >> 24305483

Identifying strategies to optimize care with oral cancer therapy.

Peg Esper1.   

Abstract

More cancer therapies are being administered via an oral route. This paradigm shift in providing cancer treatment has been met with both excitement and significant challenges for oncology practitioners. Multiple factors can impact the ability for patients to initiate and stay on oral cancer therapy. A major factor in patient adherence with oral cancer therapies is management of side effects. Side effects from therapy not only have a negative impact on a patient's quality of life but also can cause serious complications. In addition, they can impact the patient's ability to stay on therapy at optimal doses. New strategies must be designed for educating patients and caregivers, as well as for patient management and follow-up. When side effects are not managed appropriately, patients are less likely to want or be able to adhere to established treatment plans. This article explores several challenges related to the use of oral cancer therapies, with a focus on side effects seen with various classes of new targeted agents. Evidence-based practice strategies and areas in need of additional exploration and research are reviewed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24305483     DOI: 10.1188/13.CJON.629-636

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  3 in total

1.  Patient and provider perspectives on delivery of oral cancer therapies.

Authors:  Caitlin C Murphy; Simon J Craddock Lee; David E Gerber; John V Cox; Hannah M Fullington; Robin T Higashi
Journal:  Patient Educ Couns       Date:  2019-06-20

Review 2.  Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.

Authors:  Jeffrey Betcher; Elizabeth Dow; Nandita Khera
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

Review 3.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.